BIO Earnings Bio-Rad Laboratories, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–60 of 60
| Q2 2026 | 2026-06-30 | 13.85 | 2026-08-04 | 10-Q |
| Q1 2026 | 2026-03-31 | -19.55 | 2026-04-30 | 10-Q |
| Q4 2025 (derived) | 2025-12-31 | 26.59 | 2026-02-13 | 10-K |
| FY 2025 | 2025-12-31 | 27.85 | 2026-02-13 | 10-K |
| Q3 2025 | 2025-09-30 | -12.70 | 2025-10-29 | 10-Q |
| Q2 2025 | 2025-06-30 | 11.67 | 2025-07-31 | 10-Q |
| Q1 2025 | 2025-03-31 | 2.29 | 2025-05-01 | 10-Q |
| Q4 2024 | 2024-12-31 | -25.57 | 2025-02-14 | 10-K |
| FY 2024 | 2024-12-31 | -65.36 | — | — |
| Q3 2024 | 2024-09-30 | 23.34 | 2024-10-31 | 10-Q |
| Q2 2024 | 2024-06-30 | -76.26 | 2024-08-02 | 10-Q |
| Q1 2024 | 2024-03-31 | 13.45 | 2024-05-08 | 10-Q |
| Q4 2023 | 2023-12-31 | 12.14 | 2024-02-16 | 10-K |
| FY 2023 | 2023-12-31 | -21.82 | 2024-02-16 | 10-K |
| Q3 2023 | 2023-09-30 | 3.64 | 2023-10-27 | 10-Q |
| Q2 2023 | 2023-06-30 | -39.59 | — | — |
| Q1 2023 | 2023-03-31 | 2.32 | 2023-05-05 | 10-Q |
| Q4 2022 | 2022-12-31 | 27.78 | 2023-02-17 | 10-K |
| FY 2022 | 2022-12-31 | -121.79 | 2023-02-17 | 10-K |
| Q3 2022 | 2022-09-30 | -5.48 | 2022-10-28 | 10-Q |
| Q2 2022 | 2022-06-30 | -31.05 | 2022-07-29 | 10-Q |
| Q1 2022 | 2022-03-31 | -112.50 | 2022-04-29 | 10-Q |
| Q4 2021 | 2021-12-31 | -52.54 | 2022-02-11 | 10-K |
| FY 2021 | 2021-12-31 | 140.83 | 2022-02-11 | 10-K |
| Q3 2021 | 2021-09-30 | 130.02 | 2021-10-29 | 10-Q |
| Q2 2021 | 2021-06-30 | 30.41 | 2021-07-30 | 10-Q |
| Q1 2021 | 2021-03-31 | 32.46 | 2021-04-30 | 10-Q |
| Q4 2020 | 2020-12-31 | 27.81 | 2021-02-16 | 10-K |
| FY 2020 | 2020-12-31 | 126.47 | 2021-02-16 | 10-K |
| Q3 2020 | 2020-09-30 | 43.64 | 2020-10-30 | 10-Q |
| Q2 2020 | 2020-06-30 | 32.15 | 2020-07-31 | 10-Q |
| Q1 2020 | 2020-03-31 | 22.72 | 2020-05-08 | 10-Q |
| Q4 2019 | 2019-12-31 | 18.31 | 2020-03-02 | 10-K |
| FY 2019 | 2019-12-31 | 58.27 | 2020-03-02 | 10-K |
| Q3 2019 | 2019-09-30 | -8.68 | 2019-11-01 | 10-Q |
| Q2 2019 | 2019-06-30 | 19.86 | 2019-08-06 | 10-Q |
| Q1 2019 | 2019-03-31 | 28.74 | 2019-05-10 | 10-Q |
| Q4 2018 | 2018-12-31 | -27.73 | 2019-04-01 | 10-K |
| FY 2018 | 2018-12-31 | 12.10 | 2019-04-01 | 10-K |
| Q3 2018 | 2018-09-30 | 8.89 | 2018-11-05 | 10-Q |
| Q2 2018 | 2018-06-30 | 8.87 | 2018-08-09 | 10-Q |
| Q1 2018 | 2018-03-31 | 21.77 | 2018-05-10 | 10-Q |
| Q4 2017 | 2017-12-31 | 2.75 | 2018-04-16 | 10-K |
| FY 2017 | 2017-12-31 | 4.07 | 2018-04-16 | 10-K |
| Q3 2017 | 2017-09-30 | 0.73 | 2017-11-09 | 10-Q |
| Q2 2017 | 2017-06-30 | 0.17 | 2017-08-07 | 10-Q |
| Q1 2017 | 2017-03-31 | 0.41 | 2017-05-09 | 10-Q |
| Q4 2016 | 2016-12-31 | -0.63 | 2017-03-01 | 10-K |
| FY 2016 | 2016-12-31 | 0.88 | 2017-03-01 | 10-K |
| Q3 2016 | 2016-09-30 | 0.58 | 2016-11-02 | 10-Q |
| Q2 2016 | 2016-06-30 | 0.56 | 2016-08-05 | 10-Q |
| Q1 2016 | 2016-03-31 | 0.37 | 2016-05-06 | 10-Q |
| Q4 2015 | 2015-12-31 | 1.68 | 2016-02-29 | 10-K |
| FY 2015 | 2015-12-31 | 3.71 | 2016-02-29 | 10-K |
| Q3 2015 | 2015-09-30 | 0.59 | 2015-11-05 | 10-Q |
| Q2 2015 | 2015-06-30 | 0.97 | 2015-08-07 | 10-Q |
| Q1 2015 | 2015-03-31 | 0.61 | 2015-05-06 | 10-Q |
| Q4 2014 | 2014-12-31 | 1.34 | 2015-03-02 | 10-K |
| FY 2014 | 2014-12-31 | 3.05 | 2015-03-02 | 10-K |
| Q3 2014 | 2014-09-30 | 0.39 | 2014-11-07 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.